COMMON STOCK PURCHASE WARRANT ENTERO THERAPEUTICS, INC.Entero Therapeutics, Inc. • July 11th, 2024 • Pharmaceutical preparations • New York
Company FiledJuly 11th, 2024 Industry JurisdictionTHIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, ___________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Stockholder Approval Date (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on the date that is the fifth (5th) anniversary of the Stockholder Approval Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Entero Therapeutics, Inc. a Delaware corporation (the “Company”), up to 3,525,348 shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).